BUSINESS SIMULATION AND ALGORITHMIZATION OF THE REMOTE PROCESSES IN PHARMA INDUSTRY

The paper presents the transformation of the pharmaceutical industry contractors’ interactivity related to the tendencies of digitalization and globalization of the economic systems at the micro-, macro- and mega-levels. Business simulation and algorithm development of the processes of the market participants’ interaction at the remote level are the instruments of the development of the electronic business of the chemical-engineering industry.

The paper covers business simulation of the digital system of the joint-stock company “Medisorb” in the B2G, B2B, B2C sectors on the basis of developing business platforms and algorithms. The authors developed a business model showing the interaction of the joint-stock company “Medisorb” with the international partner companies, the main of which are: the near abroad countries and the CIS countries such as Latvia, Georgia, Uzbekistan, Moldova, Mongolia, etc. Sales of cluster products at the Russian level are carried out through the largest pharmaceutical companies such as JSC NPK “Katren”, JSC “Imperia Pharma”, LLC “BSS”, FC “Puls”, GC “Protek”. The authors pay attention to the issue of implementing the process of remote commercial operations as the important stage of formation of the electronic business. In the course of the research, the algorithm for implementing electronic ordering of the products for the enterprises of the B2G and B2B sectors and the algorithm for implementing electronic ordering of products for B2C enterprises are developed.

This business model will allow ensuring the effective implementation of the program for the development of the digital economy in the Russian Federation and one of the most important industries, namely, the pharmaceutical industry.